Adrenal lesions

Results after laparoscopic left anterior transperitoneal submesocolic adrenalectomy for the treatment of adrenal benign and malignant disease

Results after laparoscopic left anterior transperitoneal submesocolic adrenalectomy for the treatment of adrenal benign and malignant disease

Minimally invasive adrenalectomy is the treatment of choice for benign adrenal lesions (like Conn’s and Cushing’s syndrome) including pheocromocytoma (PHE) and in selected patients with malignant lesions, also in bilateral lesions. 

Are adrenal lesions of 6 cm or more in diameter a contraindication to laparoscopic adrenalectomy? A case-control study

BACKGROUND: The aim of this case-control study is to compare the surgical outcomes of laparoscopic adrenalectomy (LA) for lesions measuring ≥6 cm versus ≤5.9 cm in diameter. METHODS: Eighty-one patients with adrenal gland lesions ≥6 cm in diameter (intervention group) were identified.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma